Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The A-List: The Trend-Shaping Series A Financings Of 2012

This article was originally published in Start Up

Executive Summary

There’s still money for early-stage innovation despite worries to the contrary, but total dollars for Series A financings remain about one-third fewer than during the high years of the mid-2000s, and investor syndicates are mindful of making those dollars stretch as far as possible. For the 2012 A-List, our ninth, we’ve decided to ask a fundamental question as the life science venture world goes through economic upheaval: does “Series A” mean the same thing, or conjure the same connotations, as it did when the class of 2004 made the first A-List?

Advertisement

Related Content

venBio Rings In 2013 With Two Company Launches
In Cartilage Repair Histogenics Resets The Stage
In HIV Research, A Race For The Cure Is Back On Track
Avalon's Sweat Equity
The A-List: 2010's Trend-Shaping Series A Financings
The A-List: 2005's Trend-Shaping Series A Financings
The A-List: 2004's Trend-Shaping Series A Financings

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC092383

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel